Trial intelligence / Profile preview

Citalopram for 3-month functional prognosis after acute ischemic stroke

IRCT201203192150N2Phase 3Completed

Sponsor
Neuroscience Research Center
Start
May 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of citalopram in ischemic stroke, sponsored by Neuroscience Research Center. Started May 2012; status: completed.

02

Drugs

citalopram
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on IRCT201203192150N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201203192150N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call